PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
170.06%
10Y revenue/share CAGR 1.25-1.5x XRF.AX's 151.40%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
-56.63%
Negative 5Y CAGR while XRF.AX stands at 74.52%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-28.37%
Negative 3Y CAGR while XRF.AX stands at 49.22%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-428.17%
Negative 10Y OCF/share CAGR while XRF.AX stands at 132.15%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-141.38%
Negative 5Y OCF/share CAGR while XRF.AX is at 1139.05%. Joel Greenblatt would question the firm’s operational model or cost structure.
11.42%
3Y OCF/share CAGR under 50% of XRF.AX's 144.47%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
498.00%
Net income/share CAGR above 1.5x XRF.AX's 198.79% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-69.14%
Negative 5Y net income/share CAGR while XRF.AX is 195.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
2.18%
Below 50% of XRF.AX's 72.97%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
935.04%
10Y equity/share CAGR above 1.5x XRF.AX's 74.40%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
88.66%
5Y equity/share CAGR above 1.5x XRF.AX's 52.04%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
90.09%
3Y equity/share CAGR above 1.5x XRF.AX's 30.57%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.